CD274 and melanoma: Our data demonstrate that low/tolerable concentrations of M/A, achievable by oral administration, significantly suppressed PD-L1 expression on melanoma B16-F10 cells, while high concentrations of M/A (5/500 μM/μM) had no effect on this parameter (Figure 12).